Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-24T23:46:21.096Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply

Published online by Cambridge University Press:  02 January 2015

C. Glen Mayhall
C. Glen Mayhall*
Affiliation:
University of Texas Medical Branch, Galveston, Texas
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 24 , Issue 5 , May 2003 , pp. 311 - 312
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44(RR12):1–13.Google Scholar
2.Centers for Disease Control and Prevention. Vancomycin-Resistant Enterococci (VRE) and the Clinical Laboratory. Atlanta, GACenters for Disease Control and Prevention. Available at www.cdc.gov/ncidod/hip/Lab/FactSheet/vre.htm.Google Scholar
3.Centers for Disease Control and Prevention. Healthcare Coalition Successful in Controlling Vancomycin-Resistant Enterococcus (VRE). Atlanta, GACenters for Disease Control and Prevention. Available at www.cdc.gov/ncidod/hip/whats_new/nejm_vre.htm.Google Scholar
4.Ostrowsky, BE, Trick, WE, Sohn, AH, et al.Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427–1433.Google Scholar
5.Muto, CA, Giannetta, ET, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002;23:429–435.Google Scholar
6.D'Agata, EMC, Gautam, S, Green, WK, et al.High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34:167–172.Google Scholar
7.Morris, JG Jr, Shay, DK, Gebden, JN, et al.Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250–259.Google Scholar
8.Siddiqui, AH, Harris, AD, Hebden, J, Wilson, PD, Morris, JG Jr, Roghmann, M-C. The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. Am J Infect Control 2002;30:40–43.Google Scholar
9.Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234–1239.Google Scholar
10.Chang, S, Sievert, DM, Hageman, JC, et al.Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342–1347.Google Scholar